1. Home
  2. PRPO vs EVOK Comparison

PRPO vs EVOK Comparison

Compare PRPO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • EVOK
  • Stock Information
  • Founded
  • PRPO N/A
  • EVOK 2007
  • Country
  • PRPO United States
  • EVOK United States
  • Employees
  • PRPO N/A
  • EVOK N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPO Industrials
  • EVOK Health Care
  • Exchange
  • PRPO Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • PRPO 9.9M
  • EVOK 7.4M
  • IPO Year
  • PRPO N/A
  • EVOK 2013
  • Fundamental
  • Price
  • PRPO $6.65
  • EVOK $4.81
  • Analyst Decision
  • PRPO
  • EVOK
  • Analyst Count
  • PRPO 0
  • EVOK 0
  • Target Price
  • PRPO N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • PRPO 6.6K
  • EVOK 9.9K
  • Earning Date
  • PRPO 03-28-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • PRPO N/A
  • EVOK N/A
  • EPS Growth
  • PRPO N/A
  • EVOK N/A
  • EPS
  • PRPO N/A
  • EVOK N/A
  • Revenue
  • PRPO $17,411,000.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • PRPO $75.18
  • EVOK $97.35
  • Revenue Next Year
  • PRPO N/A
  • EVOK $99.52
  • P/E Ratio
  • PRPO N/A
  • EVOK N/A
  • Revenue Growth
  • PRPO 31.31
  • EVOK 100.35
  • 52 Week Low
  • PRPO $4.31
  • EVOK $3.54
  • 52 Week High
  • PRPO $7.20
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 63.80
  • EVOK 59.77
  • Support Level
  • PRPO $6.52
  • EVOK $4.68
  • Resistance Level
  • PRPO $6.90
  • EVOK $4.94
  • Average True Range (ATR)
  • PRPO 0.27
  • EVOK 0.28
  • MACD
  • PRPO 0.03
  • EVOK 0.06
  • Stochastic Oscillator
  • PRPO 89.90
  • EVOK 73.58

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: